HOME >> MEDICINE >> NEWS
Nanotechnology's miniature answers to developing world's biggest problems

f food equipment, packaging, or food; and nanotech-based sensors to detect and identify contamination;

7. Air pollution remediation: including nanotech-based innovations that destroy air pollutants with light; make catalytic converters more efficient, cheaper and better controlled; detect toxic materials and leaks; reduce fossil fuel emissions; and separate gases.

8. Construction: including nano-molecular structures to make asphalt and concrete more resistant to water; materials to block ultraviolet and infrared radiation; materials for cheaper and durable housing, surfaces, coatings, glues, concrete, and heat and light exclusion; and self-cleaning for windows, mirrors and toilets.

9. Health monitoring: several nano-devices are being developed to keep track of daily changes in patients' physiological variables such as the levels of glucose, of carbon dioxide, and of cholesterol, without the need for drawing blood in a hospital setting. This way, patients suffering from diabetes would know at any given time the concentration of sugar in their blood; similarly, patients with heart diseases would be able to monitor their cholesterol levels constantly.

10. Disease vector and pest detection control: including nano-scale sensors for pest detection, and improved pesticides, insecticides, and insect repellents.

Addressing global challenges using nanotechnology

The study team found that several developing countries have already launched nanotechnology initiatives. India's Department of Science and Technology will invest $20 million over the next four years, for example, and China ranks third in the world behind the United States and Japan in the number of nanotech patent applications.

Researchers at China's Tsinghua University have begun clinical tests for a bone scaffold based on nanotechnology which gradually disintegrates as the patient's damaged skeletal tissue heals. This application of nanotechnology is esp
'"/>


11-Apr-2005


Page: 1 2 3 4 5 6 7

Related medicine news :

1. BC physicists transmit visible light through miniature cable
2. Three-dimensional, miniature endoscope opens new diagnostic possibilities
3. Aging stem cells in mice may hold answers to diseases of the aged, Stanford study finds
4. MU researchers find mechanisms that may unlock answers to Alzheimers disease
5. How plastic is your brain? UH engineer seeks answers
6. Climate experts search for answers in the oceans
7. Getting answers
8. NCIs Patient Navigator Research Program: Questions and answers
9. Little answers to worlds biggest problems
10. Program announced to improve care in developing areas for patients with blood disorders
11. Caring for the sick now a public health priority for developing countries

Post Your Comments:
(Date:5/20/2013)... Medicare Part D seniors in plans with preferred ... access to pharmacies and other benefits, according to a ... the Pharmaceutical Care Management Association (PCMA). More than 40% ... in plans with preferred networks. , “Seniors like the ... with preferred pharmacy networks,” said PCMA President and CEO ...
(Date:5/20/2013)... A new Benefits of Pharmacy Home Delivery report ... MedEx Pack announced. The new report offers ... order to provide useful details for those who are contemplating ... MedEx Direct owner and pharmacist said, “One of the biggest ... like the MedEx Pack, patients can receive their own pre-filled ...
(Date:5/20/2013)... new report suggests that improved health care and significant ... up the age-old relationship between physicians and drug company ... unnecessary prescription drugs. , This system, which has been ... by keeping them up to date on new medications, ... get patients started on the newest drugs, as well ...
(Date:5/20/2013)... GA (PRWEB) May 20, 2013 ... nominations for this year’s prestigious Information Security Executive® ... , Awards include the Information Security Executive® ... which recognize executives who have made a positive ... protection, regulatory compliance, privacy and information security; and ...
(Date:5/20/2013)... 20, 2013 Selexis SA, a serial ... and cell line development for scale-up and manufacturing of ... will present data on the Company’s core technology at ... Conference, May 20 - 23 at the Hyatt Regency ... co-founder and scientific advisory board member, Nicolas Mermod, PhD, ...
Breaking Medicine News(10 mins):Health News:Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2Health News:Benefits of Pharmacy Home Delivery Report Published by MedEx Direct 2Health News:Breakup of physician, drug company relationship could improve health care, cut cost 2Health News:Breakup of physician, drug company relationship could improve health care, cut cost 3Health News:T.E.N. Announces Call for Nominations for the ISE® Northeast Awards 2013 2Health News:T.E.N. Announces Call for Nominations for the ISE® Northeast Awards 2013 3Health News:Selexis SA to Present Technology Platform Data at Cell Line Development & Engineering 2Health News:Selexis SA to Present Technology Platform Data at Cell Line Development & Engineering 3
(Date:5/20/2013)... , May 20, 2013  AbbVie (NYSE: ... of a Phase 3 clinical study called SONAR ... the effects of the investigational compound atrasentan - when ... kidney disease in patients with stage 2 to ... diabetes.  SONAR is a large, multinational, double-blind, placebo-controlled ...
(Date:5/19/2013)... May 20, 2013  Whole-cell pertussis vaccines were more ... during a large recent outbreak, according to a new ... pertussis vaccines, also called DTwP, were available from the ... that ultimately led to the development of acellular pertussis ... 1990s, the United States had ...
(Date:5/18/2013)... , May 18, 2013 Faruqi ... firm, is investigating potential securities fraud at AVEO ... (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) ... and its executives violated federal securities laws by ... Company,s Phase III drug trials for Tivopath (tivozanib) ...
Breaking Medicine Technology:AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2
Cached News: